CI Investments Inc
SGMO

CI Investments Inc’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

CI Investments Inc’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-150,653
Closed -$875K – 1404
2022
Q1 		$875K Buy
+150,653
New +$896K ﹤0.01% 451

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CI Investments Inc's SGMO Position: Q2 2022 in Review

CI Investments Inc sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 150,653 shares — an estimated $875K sold.

CI Investments Inc first reported a position in SGMO in Q1 2022 and held it in 1 quarter. The position peaked at $875K in Q1 2022. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • CI Investments Inc reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • CI Investments Inc sold 150,653 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $875K.
  • CI Investments Inc first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • CI Investments Inc's SANGAMO THERAPEUTICS INC position peaked at $875K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.